Table 2.
Expression of plasma miRNAs in the three groups.
| miRNAs | Mic (n = 36) |
DM (n = 40) |
NC (n = 40) |
P values |
|---|---|---|---|---|
| miR-27a-3p | 0.20 ± 0.20 | 0.66 ± 0.35 | 0.97 ± 1.87 | 0.303 |
| miR-30e | 0.60 ± 0.23#∗ | 1.16 ± 0.81 | 2.28 ± 1.25 | <0.001 |
| miR-33b | 1.20 ± 0.22 | 0.76 ± 0.32 | 0.78 ± 0.87 | 0.821 |
| miR-50 | 1.23 ± 0.63 | 1.56 ± 1.06 | 1.64 ± 1.13 | 0.854 |
| miR-125b-5p | 6.70 ± 4.64# | 1.77 ± 1.84 | 0.91 ± 0.75 | <0.001 |
| miR-150-5p | 1.47 ± 0.87#∗ | 2.68 ± 1.85 | 4.03 ± 1.15 | <0.001 |
| miR-155-5p | 3.43 ± 1.33#∗ | 5.06 ± 2.91 | 5.49 ± 2.36 | 0.002 |
| miR-296 | 1.17 ± 0.78 | 3.56 ± 2.06 | 3.64 ± 4.13 | 0.086 |
| miR-320e | 0.65 ± 0.30#∗ | 1.56 ± 1.21 | 2.38 ± 1.89 | <0.001 |
| miR-328 | 1.65 ± 1.80 | 2.00 ± 1.39 | 1.96 ± 2.26 | 0.889 |
| miR-484 | 6.06 ± 3.55# | 4.91 ± 1.64 | 2.51 ± 1.97 | 0.001 |
| miR-487 | 0.43 ± 0.30 | 0.98 ± 0.66 | 1.47 ± 1.73 | 0.120 |
| miR-550a-5p | 7.51 ± 3.51# | 6.31 ± 1.41 | 4.80 ± 1.28 | 0.005 |
| miR-590-5p | 1.07 ± 0.86 | 0.66 ± 0.54 | 0.20 ± 0.16 | 0.099 |
| miR-744 | 4.78 ± 2.26 | 4.78 ± 2.27 | 4.78 ± 2.28 | 0.836 |
| miR-885-5p | 3.34 ± 3.94 | 1.71 ± 2.05 | 1.04 ± 0.71 | 0.146 |
| miR-933 | 4.21 ± 1.26 | 5.46 ± 2.32 | 5.64 ± 1.34 | 0.842 |
| miR-3196 | 3.03 ± 1.24#∗ | 5.41 ± 2.51 | 5.91 ± 2.68 | 0.002 |
| let-7a-5p | 0.40 ± 0.37#∗ | 0.92 ± 0.36 | 1.20 ± 0.58 | 0.001 |
| let-7c-5p | 1.46 ± 0.95# | 3.71 ± 3.59 | 7.44 ± 4.74 | <0.001 |
NC: normal controls; DM: diabetes mellitus with normoalbuminuria; Mic: diabetic nephropathy with microalbuminuria. Data were presented as mean ± standard deviation (SD). ∗ P < 0.05 between DM vs. Mic; # P < 0.05 between NC vs. Mic. P values were calculated by one-way ANOVA analysis, followed by the Student–Newman–Keuls analysis.